| Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018 | 1068 | 2018 |
| Acquired mutations in TET2 are common in myelodysplastic syndromes SMC Langemeijer, RP Kuiper, M Berends, R Knops, MG Aslanyan, ... Nature genetics 41 (7), 838-842, 2009 | 943 | 2009 |
| Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes G Nikoloski, SMC Langemeijer, RP Kuiper, R Knops, M Massop, ... Nature genetics 42 (8), 665-667, 2010 | 897 | 2010 |
| Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute … D Cilloni, A Renneville, F Hermitte, RK Hills, S Daly, JV Jovanovic, ... Journal of Clinical Oncology 27 (31), 5195-5201, 2009 | 533 | 2009 |
| 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 376 | 2021 |
| Transcriptional diversity during lineage commitment of human blood progenitors L Chen, M Kostadima, JHA Martens, G Canu, SP Garcia, E Turro, ... Science 345 (6204), 1251033, 2014 | 322 | 2014 |
| The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia B Linggi, C Müller-Tidow, L Van De Locht, M Hu, J Nip, H Serve, ... Nature Medicine 8 (7), 743-750, 2002 | 315 | 2002 |
| The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING‐IBR‐RING domain and the unique LDD extension JJ Smit, D Monteferrario, SM Noordermeer, WJ Van Dijk, ... The EMBO journal 31 (19), 3833-3844, 2012 | 247 | 2012 |
| Gfi1 and Gfi1b: key regulators of hematopoiesis LT Van der Meer, JH Jansen, BA Van Der Reijden Leukemia 24 (11), 1834-1843, 2010 | 229 | 2010 |
| Evaluating variant calling tools for non-matched next-generation sequencing data S Sandmann, AO De Graaf, M Karimi, BA Van Der Reijden, ... Scientific reports 7 (1), 43169, 2017 | 228 | 2017 |
| A Dominant-Negative GFI1B Mutation in the Gray Platelet Syndrome D Monteferrario, NA Bolar, AE Marneth, KM Hebeda, SM Bergevoet, ... New England Journal of Medicine 370 (3), 245-253, 2014 | 178 | 2014 |
| Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients H Dolstra, MWH Roeven, J Spanholtz, BN Hangalapura, M Tordoir, ... Clinical Cancer Research 23 (15), 4107-4118, 2017 | 171 | 2017 |
| Clonal evolution in myelodysplastic syndromes P da Silva-Coelho, LI Kroeze, K Yoshida, TN Koorenhof-Scheele, ... Nature communications 8 (1), 1-11, 2017 | 159 | 2017 |
| Breast cancer resistance protein in drug resistance of primitive CD34+ 38− cells in acute myeloid leukemia MHGP Raaijmakers, EPLM de Grouw, LHH Heuver, BA van der Reijden, ... Clinical cancer research 11 (6), 2436-2444, 2005 | 141 | 2005 |
| Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome M Luesink, JLA Pennings, WM Wissink, PCM Linssen, P Muus, R Pfundt, ... Blood, The Journal of the American Society of Hematology 114 (27), 5512-5521, 2009 | 139 | 2009 |
| Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative … JV Jovanovic, A Ivey, AM Vannucchi, E Lippert, E Oppliger Leibundgut, ... Leukemia 27 (10), 2032-2039, 2013 | 129 | 2013 |
| Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis AO de Graaf, LP Van Den Heuvel, HBPM Dijkman, RA De Abreu, ... Experimental cell research 299 (2), 533-540, 2004 | 122 | 2004 |
| Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders JM Bastida, ML Lozano, R Benito, K Janusz, V Palma-Barqueros, ... haematologica 103 (1), 148, 2018 | 117 | 2018 |
| 5-Hydroxymethylcytosine: an epigenetic mark frequently deregulated in cancer LI Kroeze, BA van der Reijden, JH Jansen Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1855 (2), 144-154, 2015 | 116 | 2015 |
| MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells AM Schaap-Oziemlak, RA Raymakers, SM Bergevoet, C Gilissen, ... Stem cells and development 19 (6), 877-885, 2010 | 114 | 2010 |
